Ines G. B.
- Country
- Spain
- Department
- Medical Oncology
Research Overview
- Comparative Study of JPB898 and Nivolumab in Combination with Ipilimumab for Advanced Unresectable/Metastatic Melanoma
- Phase 3 Randomized Controlled Trial of Adjuvant mRNA-4157 and Pembrolizumab Versus Placebo and Pembrolizumab in High-Risk Stage II-IV Melanoma
- Phase 3 Evaluation of Fianlimab and Cemiplimab Versus Pembrolizumab in Treatment-Naïve Unresectable Locally Advanced or Metastatic Melanoma
Data & Insights
Has run more than one trial at 100 of 218 partner sites.
Specializations
Oncology Focus
The investigator specializes in the treatment of advanced melanoma, with particular emphasis on managing unresectable and metastatic cases.
- Melanoma Treatment
- Advanced Stage Cancer Management
- Skin Cancer Therapeutics
Their research interests encompass innovative approaches in treating aggressive forms of skin cancer.
Immunotherapy Research
The investigator focuses on immunotherapeutic approaches in cancer treatment, particularly exploring combination therapies for advanced melanoma.
- Combination Immunotherapy
- Biological Therapeutics
- Treatment Response Assessment
Their work involves evaluating novel therapeutic options for patients with advanced skin malignancies.
Biosimilar Development
The investigator is involved in research concerning biosimilar therapeutics in oncology, focusing on establishing treatment equivalence and safety profiles.
- Comparative Effectiveness Studies
- Safety Assessment
- Pharmacological Evaluation
Their expertise extends to evaluating novel therapeutic alternatives in cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.